Summary: Zacks Premium tools highlight QIAGEN (QGEN) as a strong momentum stock for investors.

From Nasdaq: 2024-12-30 09:50:04

Zacks Premium offers tools to help investors navigate the stock market. From Zacks Rank updates to Equity Research reports, investors can make informed decisions. Style Scores like Value, Growth, and Momentum provide additional insights into stock performance. By combining these scores with the Zacks Rank, investors can maximize their chances of success.

QIAGEN N.V. (QGEN) is a top provider of DNA/RNA technologies. With a #3 (Hold) Zacks Rank and a VGM Score of B, QGEN shows promise for investors. The stock has a strong Momentum Style Score and positive earnings estimate revisions. With a solid Zacks Rank and high Style Scores, QGEN is worth considering for investment.

Zacks Investment Research provides valuable tools for investors. With a proven track record of success and a focus on independent research, Zacks offers insights to help investors make informed decisions. By utilizing Zacks Rank and Style Scores, investors can identify top-performing stocks and build a successful portfolio.



Read more at Nasdaq: Here’s Why Qiagen (QGEN) is a Strong Momentum Stock